supplementary figure 3

1
Supplementary Figure 3 HCT116-TP53KO 0 1 2 3 4 5 6 siLUC siATG5 si ATG7 IC50 5FU (µM) HCT116 0 1 2 3 4 5 6 7 siLUC siATG5 si ATG7 IC50 5FU (µM) GAPDH LC3 NT NT 5FU 5FU Ox Ox HCT116 HCT116-TP53KO A B C D E F 0 1 2 3 4 5 HCT116 HCT116 TP53KO IC50 5FU (µM) 0 1 2 HCT116 HCT116 TP53KO IC50 Oxaliplatin (µM) 0 0.1 0.2 0.3 0.4 siLUC si ATG5 si ATG7 IC50 Oxaliplatin (µM) HCT116 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 siLUC si ATG5 si ATG7 IC50 Oxaliplatin (µM) HCT116-TP53KO

Upload: august-curry

Post on 31-Dec-2015

45 views

Category:

Documents


0 download

DESCRIPTION

HCT116. HCT116-TP53KO. NT. 5FU. Ox. NT. 5FU. Ox. 5. 2. 4. LC3. 3. IC50 5FU (µM). 1. IC50 Oxaliplatin (µM). 2. 1. GAPDH. 0. 0. HCT116. HCT116 TP53KO. HCT116. HCT116 TP53KO. 6. 5. 4. 7. HCT116. IC50 5FU (µM). 3. 6. HCT116. 0.4. 2. 5. 4. 1. 0.3. IC50 5FU (µM). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Supplementary Figure 3

Supplementary Figure 3

HCT116-TP53KO

0

1

2

3

4

5

6

siLUC siATG5 si ATG7

IC50

5F

U (

µM

)

HCT116

0

1

2

3

4

5

6

7

siLUC siATG5 si ATG7

IC50

5F

U (

µM

)

GAPDH

LC3

NT NT5FU 5FU OxOx

HCT116 HCT116-TP53KO

A B

CD

E F

012

345

HCT116 HCT116TP53KO

IC50

5F

U (

µM

)

0

1

2

HCT116 HCT116TP53KO

IC50

Oxa

lipla

tin (

µM

)

0

0.1

0.2

0.3

0.4

siLUC si ATG5 si ATG7

IC50

Oxa

lipla

tin (

µM

) HCT116

0

0.2

0.4

0.6

0.81

1.2

1.4

1.6

siLUC si ATG5 si ATG7

IC50

Oxa

lipla

tin (

µM

)

HCT116-TP53KO